Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GHSR | Q92847 | 5/20 | 0.60 |
| ▸ | NPY1R | P25929 | 3/20 | 0.58 |
| ▸ | NPY2R | P49146 | 3/20 | 0.58 |
| ▸ | NPY4R | P50391 | 3/20 | 0.58 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.56 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.55 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.55 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.55 |
| ▸ | IL1RN | P18510 | 1/20 | 0.54 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.54 |
| ▸ | NPBWR1 | P48145 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31105632 | 0.94 | NPY1R (0.65) | GHSRNPY1RNPY2RNPY4RUTS2R | |
| SCHEMBL29508714 | 0.94 | GHSR (0.64) | GHSRNPY1RNPY2RNPY4RUTS2R | |
| SCHEMBL31731732 | 0.93 | GHSR (0.62) | GHSRNPY1RNPY2RNPY4RUTS2R | |
| SCHEMBL29508679 | 0.92 | GHSR (0.64) | GHSRNPY1RNPY2RNPY4RUTS2R | |
| SCHEMBL29508662 | 0.92 | GHSR (0.63) | GHSRNPY1RNPY2RNPY4RERAP2 | |
| SCHEMBL29362220 | 0.91 | OPRM1 (0.59) | NPY1RNPY2RNPY4RERAP2ERAP1 | |
| SCHEMBL30518081 | 0.91 | GHSR (0.63) | GHSRNPY1RNPY2RNPY4RIL23R | |
| SCHEMBL30495592 | 0.90 | UTS2R (0.58) | GHSRNPY1RNPY2RNPY4RUTS2R | |
| SCHEMBL30506399 | 0.89 | LTA4H (0.56) | GHSRERAP2 | |
| SCHEMBL29425246 | 0.89 | GHSR (0.60) | GHSRNPY1RNPY2RNPY4RERAP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | WINKEY TECH USA INC (US) | 2026-03-19 | — | — | US | claimed |
| WO-2024217503-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-10-24 | — | — | WO | claimed |
| CN-116535463-A | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2023-08-04 | — | — | CN | claimed |
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | WINKEY TECH USA INC (US) | 2026-03-19 | — | — | US | disclosed |
| WO-2024217503-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | 深圳市维琪科技股份有限公司 | 2024-10-24 | — | — | WO | disclosed |
| CN-117343140-B | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-117343140-A | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-116535463-B | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-116535463-A | Active peptide, composition and use thereof | 深圳市维琪科技股份有限公司 | 2023-08-04 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078144-A1 | ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF | ARGLU1, ARG1, POT1 | GHSR 372/4885NPY1R 8/4885NPY2R 47/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.